Log in with your email address username.


[Correspondence] Corticosteroid therapy for pneumonia – Author’s reply

Ar Kar Aung and colleagues state that the slow rate of inclusion in our study1 could have resulted in a selection of patients with mild community-acquired pneumonia (CAP). A slow rate of inclusion is a common and expected problem in randomised controlled trials (RCTs) using corticosteroids.2 To limit potential selection of patients with mild CAP, we had ethics committee approval to include patients with temporary inability for informed consent because of severe disease with consent of next of kin, assuring that the most severe cases were also included.